Reaction Details Report a problem with these data
Target
Mu-type opioid receptor
Ligand
BDBM50514539
Substrate
n/a
Meas. Tech.
ChEMBL_1857508 (CHEMBL4358237)
Ki
71±n/a nM
Citation
 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisaṇ, CA; Brugnoli, A; Morari, M; Zaveri, NT Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models. J Med Chem 63:2688-2704 (2020) [PubMed]  Article 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM50514539
Synonyms:
CHEMBL4460695
Type:
Small organic molecule
Emp. Form.:
C24H36N4S
Mol. Mass.:
412.634
SMILES:
CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(52.76,-21.76,;51.95,-20.45,;52.68,-19.09,;50.41,-20.49,;49.6,-19.19,;48.05,-19.23,;47.33,-20.58,;48.14,-21.89,;49.67,-21.85,;45.79,-20.64,;45.06,-21.99,;43.53,-22.04,;42.71,-20.74,;43.43,-19.38,;44.98,-19.33,;41.17,-20.79,;40.23,-19.58,;38.78,-20.1,;37.51,-19.25,;36.13,-19.92,;34.86,-19.07,;33.48,-19.74,;34.96,-17.54,;38.84,-21.64,;37.73,-22.71,;38.11,-24.2,;39.59,-24.62,;40.69,-23.55,;40.32,-22.07,)|
Structure:
Search PDB for entries with ligand similarity: